socalTechnews
Log in | Join | Subscribe

Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
  • Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
  • About
  • Membership
  • About
  • Contact Us

  • Search News
    Thursday, March 29, 2007

    SenoRx Prices IPO


    Aliso Viejo-based SenoRx has priced its IPO, saying today that it will offer 5,500,000 shares of its common stock at $8.00 per share. SenoRx will trade on the Nasdaq Global Market as "SENO". The firm's IPO is being underwritten by Bank of America Securities, Citigroup Markets, Cowen and Company, and Canaccord Adams. SenoRx is developing medical diagnostics for breast cancer, and is venture backed by CIT Venture Capital, DeNovo Ventures, Domain Associates, Mayfield, and MPM Capital.
    posted on Thursday, March 29, 2007

    Related companies:
    SenoRx

    Related stories:
    > SenoRx Sets IPO Terms
    > Obagi Medical Prices IPO
    > WebSideStory Prices IPO
    > Interview with Martin Andersen, General Manager of PriceRunner US
    > eCost Opens Membership Program

    RSS subscri
be via emailEmail Twitter


    Previous news:

    Monday, December 1, 2008
    Wednesday, November 26, 2008
    Tuesday, November 25, 2008
    Monday, November 24, 2008
    Friday, November 21, 2008